Evaluation of Nauclea diderrichii (De Wild.) Merrill Leaf Extracts and Fractions against Some Clinical Bacterial Isolates from Urinary Tract Infections
doi.org/10.26538/tjnpr/v3i7.3
Keywords:
Nauclea diderrichii, Urinary tract infections, Uropathogens,, Chromatographic fractionation,, Secondary metabolites.Abstract
Urinary tract infections (UTIs) constitute considerable health and economic burdens globally. The advent of resistant strains of uropathogens coupled with high rate of recurrent UTIs has heightened the precarious situation. Consequently, research efforts are being directed towards alternative treatment solutions. This study investigated the potential of Nauclea diderrichii leaf extracts and fractions as antibacterial agents against some clinical uropathogen isolates. Chloroform, acetone and methanol extracts of dried leaf of N. diderrichii, obtained by cold maceration, were evaluated for antibacterial activity against five different species (2 strains each) of clinical uropathogenic bacterial isolates from UTI; namely: Proteus mirabilis, Escherichia coli, Klebsiella pneumoniae, Enterobacter feacalis and Pseudomonas aeruginosa. The secondary metabolites present in these extracts were investigated by qualitative phytochemical screening. The most active extract was subjected to chromatographic fractionation, while the minimum inhibitory concentrations (MICs) of the fractions were determined. Chloroform extract exhibited activity against all the strains with inhibition zone diameters of 10 mm – 19 mm, while methanol and acetone extracts showed some activity against some of the organisms with inhibition zone diameters of 10 mm – 18 mm and 12 mm – 16 mm, respectively. Phytochemical screening revealed the presence of saponins, alkaloids, anthraquinones, terpenoids, cardiac glycosides, phenolics and flavonoids. Fractionation of the chloroform extract yielded three fractions, with MICs: 0.78125 – 25 mg/mL, fraction C; 1.5625– 12.5 mg/mL, fraction B; and 1.5625 – 25 mg/mL, fraction A. This study confirmed that N. diderrichii leaf contains bioactive compounds against UTI-causing uropathogens.
References
Barber AE, Norton JP, Spivak AM, Mulvey MA. Urinary tract infections: current and emerging management strategies. Clin Infect Dis. 2013; 57(5):719-724.
Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002; 113(suppl 1A):14S-19S.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5):269-284.
Rafsanjany N, Sendker J, Lechtenberg M, Petereit F, Scharf B, Hensel A. Traditionally used medicinal plants against uncomplicated urinary tract infections: are unusual, flavan- 4-ol- and derhamnosylmaysin derivatives responsible for the antiadhesive activity of extracts obtained from stigmata of Zea mays L. against uropathogenic E. coli and benzethonium chloride as frequent contaminant faking potential antibacterial activities? Fitoterapia 2015; 105:246- 253.
Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Compl Altern Med. 2011; 11:117.
Di Giorgio C, Lamidi M, Delmas F, Balansard G, Ollivier E. Antileishmanial activity of quinovic acid glycosides and cadambine acid isolated from Nauclea diderrichii. Planta Med. 2006; 72(15):1396-1402.
Haudecoeur R, Peuchmaur M, Pérès B, Rome M, Taïwe GS, Boumendjel A, Boucherle B. Traditional uses, phytochemistry and pharmacological properties of African Nauclea species: a review. J Ethnopharmacol. 2018; 212:106-136.
Agnaniet H, Mbot EJ, Keita O, Fehrentz J-A, Ankli A, Gallud A, Garcia M, Gary-Bobo M, Lebibi J, Cresteil T, Menut C. Antidiabetic potential of two medicinal plants used in Gabonese folk medicine. BMC Compl Altern Med. 2016; 16(1):71.
Adeoye AO, Waigh RD. Secoiridoid and triterpenic acids from the stems of Nauclea diderrichii. Phytochem 1983; 22(4):975-978.
Lamidi M, Ollivier E, Faure R, Debrauwer L, Nze-Ekekang L, Balansard G. Quinovic acid glycosides from Nauclea diderrichii. Phytochem 1995; 38(1):209-212.
Cheesbrough M. District laboratory practice in tropical countries. (Part 2). Cambridge: University Press; 2000. 188- 189 p.
Sofowora A. Medicinal plants and traditional medicine in Africa. Ibadan: Spectrum Books Limited; 1993. 261-268 p.
CLSI - Clinical and Laboratory Standards Institute, Guidelines. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa; 2011.
Ozumba UC. Increasing incidence of bacterial resistance to antibiotics by isolates from the urinary tract. Nig J Clin Pract. 2005; 8(2):107-109.
Albrecht U, Goos K, Schneider B. A randomised, double- blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin. 2007; 23(10):2415-2422.
Lüthje P and Brauner A. Novel strategies in the prevention and treatment of urinary tract infections. Pathogens 2016; 5(13):1-14.
Savoia D. Plant-derived antimicrobial compounds: alternatives to antibiotics. Fut Microbiol. 2012; 7(8):979- 990.
Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999; 12(4):564-582.
Khan M, Amupitan J, Sudi I. Antimicrobial activity and isolation of methylated flavanone from methanol stem-bark extract of Nauclea diderrichii. Int J Biochem Res Rev. 2017; 18(2):1-10.
Akunne TC, Obi BC, Akpa PA, Sunday O, Anaenugwu AJ. Antibacterial, antifungal and wound healing potentials of extract and fractions of Nauclea diderrichii root bark. Int J Trad Compl Med. 2017; 2(1):1-8.
Ahoua ARC, Konan AG, Bonfoh B, Koné MW. Antimicrobial potential of 27 plants consumed by chimpanzees (Pan troglodytes verus Blumenbach) in Ivory Coast. BMC Compl Altern Med. 2015; 15:383.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
